Maganti Lab

A multi-disciplinary approach to understand Hematopoietic Stem Cell biology

Publications

Discover a selection of pivotal publications authored by various members of Maganti lab with contribution from other labs, which underpin the research endeavors of our lab. These works reflect the rigorous scientific inquiry and collaborative ethos propelling our advancements in stem cell research and its therapeutic applications. Each entry below is a testament to the knowledge and expertise anchoring our lab’s mission.

Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective
https://www.mdpi.com/1718-7729/31/2/44
Tanvir Hasan*, Ajay Ratan Pasala*, Dhuha Hassan, Justine Hanotaux, David S. Allan, Harinad B. Maganti
*Co-first authors
Curr. Oncol. 2024, 31(2), 603-616; https://doi.org/10.3390/curroncol31020044 (registering DOI)
AA2P-mediated DNA demethylation synergizes with stem cell agonists to promote expansion of hematopoietic stem cells
https://www.cell.com/cell-reports-methods/fulltext/S2667-2375(23)00340-5
https://pubmed.ncbi.nlm.nih.gov/38070507/
Javed K Manesia*, Harinad B Maganti*, Sakhar AlmoflehiSuria JahanTanvir HasanRoya PashaChelsea McGregorNellie DumontJosée LaganièreJulie AudetNicolas Pineault
*Co-first authors
Cell Reports Methods. December 08, 2023. DOI:https://doi.org/10.1016/j.crmeth.2023.100663 PMID: 38070507
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies https://pubmed.ncbi.nlm.nih.gov/35039239/
Harinad B MagantiAidan M KirkhamAdrian J M BaileyRisa ShorrNatasha KekreNicolas PineaultDavid S Allan
Cytotherapy. 2022 Apr;24(4):405-412. doi: 10.1016/j.jcyt.2021.10.010. Epub 2022 Jan 14. PMID: 35039239
Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies
https://pubmed.ncbi.nlm.nih.gov/33666363/
Harinad B MagantiAdrian J M BaileyAidan M KirkhamRisa ShorrNicolas PineaultDavid S Allan
Stem Cells Transl Med. 2021 Jul;10(7):996-1007. doi: 10.1002/sctm.20-0520. Epub 2021 Mar 5. PMID: 33666363; PMCID: PMC8235122
Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies
https://pubmed.ncbi.nlm.nih.gov/36396108/
Tana SaiyinAidan M KirkhamAdrian J M BaileyRisa ShorrNicolas PineaultHarinad B MagantiDavid S Allan
Transplant Cell Ther. 2023 Feb;29(2):129.e1-129.e9. doi: 10.1016/j.jtct.2022.11.007. Epub 2022 Nov 15. PMID: 36396108
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
https://pubmed.ncbi.nlm.nih.gov/30115703/
Harinad B MagantiHani JradeChristopher CafarielloJanet L Manias RothbergChristopher J PorterJulien Yockell-LelièvreHannah L BattaionSafwat T KhanJoel P HowardYuefeng LiAdrian T GrzybowskiElham SabriAlexander J RuthenburgF Jeffrey DilworthTheodore J PerkinsMitchell SabloffCaryn Y ItoWilliam L Stanford
Cancer Discov. 2018 Nov;8(11):1376-1389. doi: 10.1158/2159-8290.CD-17-0841. Epub 2018 Aug 16. PMID: 30115703; PMCID: PMC7200079
Mtf2-PRC2 control of canonical Wnt signaling is required for definitive erythropoiesis
https://pubmed.ncbi.nlm.nih.gov/29736258/
Janet L Manias RothbergHarinad B MagantiHani JradeChristopher J PorterGareth A PalidworChristopher CafarielloHannah L BattaionSafwat T KhanTheodore J PerkinsRobert F PaulsonCaryn Y ItoWilliam L Stanford
Cell Discov. 2018 May 1;4:21. doi: 10.1038/s41421-018-0022-5. PMID: 29736258; PMCID: PMC5928144